Sen. Bernie Sanders (I-VT) (AP Photo/Jacquelyn Martin, File)
March 28, 2024 11:45 AM EDT
Pharma
FDA+

Bernie Sanders im­plores No­vo to cut list prices of Ozem­pic, We­govy

Lia DeGroot

Sen­ate HELP Com­mit­tee Chair Bernie Sanders (I-VT) is call­ing on No­vo Nordisk to dra­mat­i­cal­ly low­er the list prices of Ozem­pic and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times